Report
Guy Sips

Amoéba Partnership with Syngenta for cereals and field crops in EU and UK

We welcome that Syngenta and Amoeba will develop and commercialize biocontrol solutions for EU and UK.
We reiterate our Buy rating and € 1.5 Target Price.
Underlying
Amoeba SA

Amoeba SA. Amoeba SA is a France-based company that develops, manufactures and markets biological products. The Company specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The Company's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The Company is engaged in various technical, commercial, industrial and investment partnerships.

Provider
KBC Securities
KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

 

Analysts
Guy Sips

Other Reports on these Companies
Other Reports from KBC Securities
Guy Sips ... (+4)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Wim Hoste
Guy Sips ... (+4)
  • Guy Sips
  • Jacob Mekhael
  • Livio Luyten
  • Wim Hoste

ResearchPool Subscriptions

Get the most out of your insights

Get in touch